Pregnancy After Tension-free Vaginal Tape and Other Mid-urethral Sling Procedures
PregnanT
The PregnanT-study: Pregnancy Outcomes After TVT and Other Mid-urethral Sling (MUS) Procedures
1 other identifier
observational
80
1 country
1
Brief Summary
The purpose of this study is to determine the interactions between pregnancy and urinary stress incontinence in women with a mid-urethral sling (MUS). The specific aims of the 2 sub studies are: Study 1: The main aims of Study 1 are to evaluate any potential impact on urinary stress continence after a pregnancy/delivery following MUS surgery, and to evaluate any potential differences in continence status based on the mode of delivery for these women. Study 2: The aim of Study 2 is to examine how obstetric factors may affect the degree of incontinence in women registered in The Norwegian female incontinence registry prior to surgical treatment. In addition, we want to explore if there are obstetric risk factors predicting failure of a MUS surgery performed after pregnancy/delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 19, 2016
CompletedFirst Posted
Study publicly available on registry
December 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedFebruary 15, 2019
February 1, 2019
3.7 years
December 19, 2016
February 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Subjective stress incontinence rates
Defined as the percentage of women having a stress incontinence index score \< 5 on the validated questionnaire compared to women of equal age and follow-up time (also having undergone MUS surgery) not having undergone a subsequent delivery (controls)
Up to ten years
Treatment satisfaction rate
Defined as the percentage of women stating "very satisfied" on the validated questionnaire in both cases and Controls.
Up to ten years
The percentage of women not using urinary incontinence pads
Up to ten years
Any potential differences in subjective stress continence rates, the rate of women not using pads and treatment satisfaction rates based on the mode of delivery (spontaneous vaginal, operative vaginal and cesarean section)
Up to ten years
Secondary Outcomes (7)
Any potential adverse effects of undergoing a subsequent delivery after previous MUS surgery
Up to ten years
The continence status during pregnancy (before delivery) and whether any subjective incontinence was persistent or transient after delivery
Up to ten years
The effect of time from MUS to subsequent delivery on stress continence status
Up to ten years
The impact on stress continence status from having undergone more than one subsequent delivery after MUS
Up to ten years
Differences in urgency score between controls and cases
Up to ten years
- +2 more secondary outcomes
Study Arms (2)
Cases
Women having undergone at least one pregnancy/delivery after their MUS surgery
Controls
Every case will be matched with two controls. The controls will be matched with the study cases' age and year of surgery (+- 2 years of age if a perfect match is not obtainable). These controls have not undergone a subsequent pregnancy/delivery.
Eligibility Criteria
Women included in the Norwegian Female Incontinence Registry.
You may qualify if:
- Cases, consisting of women identified by the coupling of The Norwegian female incontinence registry and The medical birth registry of Norway as having undergone at least one pregnancy/delivery after their MUS surgery
- Controls, consisting of randomly selected women from Ullevål Hospital registered in the The Norwegian female incontinence registry with MUS surgery. Every case will be matched with two controls. The women will be matched with the study cases' age and year of surgery (+- 2 years of age if a perfect match is not obtainable). These controls have not undergone a subsequent pregnancy/delivery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gynekologisk avdeling, Oslo Universitetssykehus Ullevål
Oslo, 0424, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 19, 2016
First Posted
December 21, 2016
Study Start
August 1, 2014
Primary Completion
April 1, 2018
Study Completion
August 1, 2018
Last Updated
February 15, 2019
Record last verified: 2019-02